Our previous studies showed that abnormal expression of T-cell immunoreceptor with immunoglobulin and ITIM domains (TIGIT) on NK cells plays an important role in the pathogenesis of SLE, which suggests that the TIGIT signaling pathway may serve as a potential therapeutic target for treating this disease [12]. Here, TIGIT is linked to systemic lupus erythematosus.